Journal
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
Volume 28, Issue 13, Pages 1426-1434Publisher
OXFORD UNIV PRESS
DOI: 10.1177/2047487319893046
Keywords
Myocardial infarction; peripheral arterial disease; cardiovascular events; mortality; treatment patterns; sex differences
Categories
Funding
- AstraZeneca
Ask authors/readers for more resources
This study compared the differences in comorbidity, treatment patterns, cardiovascular outcomes, and mortality between myocardial infarction (MI) and peripheral arterial disease (PAD) patients, with a focus on sex differences. The results showed that PAD patients were less intensively treated and had a higher cardiovascular mortality than MI patients. Women with PAD were less likely than men to present with established polyvascular disease, while the opposite was true for women with MI, suggesting differences in atherosclerosis presentation between the two conditions.
Background Differences in comorbidity, pharmacotherapy, cardiovascular (CV) outcome, and mortality between myocardial infarction (MI) patients and peripheral arterial disease (PAD) patients are not well documented. Aim The aim of this study was to compare comorbidity, treatment patterns, CV outcome, and mortality in MI and PAD patients, focusing on sex differences. Methods This observational, population-based study used data retrieved from mandatory Swedish national registries. The risks of MI and death were assessed by Kaplan-Meier analysis. Secondary preventive drug use was characterized. Cox proportional risk hazard modelling was used to determine the risk of specific events. Results Overall, 91,808 incident MI patients and 52,408 PAD patients were included. CV mortality for MI patients at 12, 24, and 36 months after index was 12.3%, 19.3%, and 25.4%, and for PAD patients it was 15.5%, 23.4%, and 31.0%. At index, 89% of MI patients and 65% of PAD patients used aspirin and 74% and 53%, respectively, used statins. Unlike MI women, women with PAD had a lower rate of other CV-related comorbidities and a lower risk of CV events (age-adjusted hazard ratio 0.81, 95% confidence interval 0.79-0.84), CV death (0.78, 0.75-0.82), and all-cause death (0.78, 0.76-0.80) than their PAD male counterparts. Conclusion PAD patients were less intensively treated and had a higher CV mortality than MI patients. Women with PAD were less likely than men to present with established polyvascular disease, whereas the opposite was true of women with MI. This result indicates that the lower-limb vasculature may more often be the index site for atherosclerosis in women.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available